1.8460
+0.0120
+(0.65%)
At close: April 17 at 9:55:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-49,410
-49,410
-52,638
11,284
-14,267
Investing Cash Flow
-56,980
-56,980
-4,858
-13,578
-21,422
Financing Cash Flow
60,522
60,522
8,167
-575
3,767
End Cash Position
20,829
20,829
66,697
116,026
118,895
Income Tax Paid Supplemental Data
17
17
194
100
102
Interest Paid Supplemental Data
2,566
2,566
44
34
14
Capital Expenditure
-4,305
-4,305
-4,418
-8,307
-13,828
Issuance of Capital Stock
31,319
31,319
8,652
--
--
Issuance of Debt
29,521
29,521
--
--
--
Free Cash Flow
-53,715
-53,715
-57,056
2,977
-28,095
12/31/2021 - 5/23/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4AJ0.BE Alk-Abello A/S
19.68
+2.23%
8C5.F Coherus BioSciences, Inc.
0.8802
-4.37%
CXF.F Chimerix, Inc.
7.48
+0.27%
ITH.F Nektar Therapeutics
0.5740
+5.03%
I5X.F Precigen, Inc.
1.1700
-2.42%
LEXXW Lexaria Bioscience Corp.
0.3400
-8.11%
IPIX Innovation Pharmaceuticals Inc.
0.0002
0.00%
NEUP Neuphoria Therapeutics Inc.
5.14
+0.38%
TSVT 2seventy bio, Inc.
4.9800
+0.20%
AEON AEON Biopharma, Inc.
0.4050
+1.28%